$2.76
-0.32 (-10.39%)
Corcept Therapeutics, Inc. (NASDAQ:CORT)
CAPS Rating:
A pharmaceutical company which is engaged in the development of drugs for the treatment of severe psychiatric and metabolic diseases.
A pharmaceutical company which is engaged in the development of drugs for the treatment of severe psychiatric and metabolic diseases.